Here are some highlights from the conference, including some slides from the company presentations I found most interesting and potentially helpful in aging and longevity.
Note, unless otherwise mentioned, you should expect that most of these companies are fund-raising these days. Accredited investors writing large checks, and venture capitalists should definitely contact these companies if they are interested in this area; I think these companies have the potential to really move the needle in longevity biotech. Each of the companies below have already had their seed or series A round, and are planning additional funding.
Note: if you just want to view the slides easily, you can click on any of the images to make it larger, then arrows on the left and right of the image will allow you to navigate through the entire set of images.
The Buck: https://www.buckinstitute.org
The company Oviva is a biotech startup that is focused on extending the healthy fertility of women, as well as ovarian function for healthier longevity. The company seems well on its way, and could really help improve women’s health in many important areas. Following is a highlight of their presentation.
A conversation that came up at the conference in the Q&A with some of the speakers. We hear a lot about all these billionaire guys who are investing in longevity. Why are there no women billionaires (think MacKenzie Scott, Laurene Powell Jobs, etc.) investing in female longevity? They need to start!
Buy their product here: https://www.monchmonch.shop
Robert Lustig was presenting on Biolumen’s unique type of fiber supplement. One thing I discovered was that Biolumen is already selling their product, and that it is really competitive with some of the products like Acarbose that help manage blood sugar peaks. I will report back when I find out how to purchase their product, because its not obvious from their website that they are selling it. (Note: I’ve found it, here is their site for buying the product: https://www.monchmonch.shop )
I really like the look of the product, and think the company will be successful (they are currently fund raising, for a series A). Robert said their product has tested better than Inulin for SCFA production, and much better than Acarbose, in that it causes no Gastro intestinal issues. I look forward to trying it and reporting on it in the future.
Perhaps the most interesting slide in the Mitrix presentation was the Age Reversal slide where they talked about how administering their new mitochondria to mice resulted in significant rejuvenation effects, with youthful hair growth, better cognitive performance, etc. Exciting results! See the second to last slide below from Mitrix.